生命科学资讯

New TEAD inhibitors disclosed in Signet Therapeutics patent

Jiangsu Simcere Biologics discovers new bispecific ADCs

Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq

AstraZeneca bets up to $2B on Jacobio’s pan-KRAS inhibitor for cancer

AstraZeneca fronts $100M for Jacobio's clinical-stage pan-KRAS inhibitor

AstraZeneca flunks phase 3 lung cancer test in further setback to synthetic lethal mechanism

Wasatch Biolabs announces co-marketing agreement with Agilent to advance native-read targeted sequencing - News-Medical

AGILENT TECHNOLOGIES, INC. SEC 10-K Report - TradingView — Track All Markets

Agilent Technologies : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com

Osaic Holdings Inc. Has $8.02 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat

Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline

CCLA Investment Management Sells 16,843 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues

Whole genome sequencing of hepatitis A virus: adapting Illumina protocols for foodborne investigation - Nature

Is There Now An Opportunity In Lonza Group AG (VTX:LONN)? - simplywall.st

Agilent Technologies opens India refurbishment center to promote sustainable science - FoodTechBiz

ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka

Cerebellar climbing fibers impact experience-dependent plasticity in the mouse primary somatosensory cortex

Afadin-deficient mouse retinas exhibit severe neuronal lamination defects but preserve visual functions

Cone bipolar cell synapses generate transient versus sustained signals in parallel ON pathways of the mouse retina